172 related articles for article (PubMed ID: 33670609)
1. Expression of Genomic Instability-Related Molecules: Cyclin F, RRM2 and SPDL1 and Their Prognostic Significance in Pancreatic Adenocarcinoma.
Klimaszewska-Wiśniewska A; Buchholz K; Neska-Długosz I; Durślewicz J; Grzanka D; Zabrzyński J; Sopońska P; Grzanka A; Gagat M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670609
[TBL] [Abstract][Full Text] [Related]
2. SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer.
Klimaszewska-Wiśniewska A; Buchholz K; Durślewicz J; Villodre ES; Gagat M; Grzanka D
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163739
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
Tian X; Wang N
Oncol Lett; 2020 Apr; 19(4):3307-3315. PubMed ID: 32218868
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis combined with experiments explores the oncogenic role of spindle apparatus coiled-coil protein 1 (SPDL1).
Song P; Wusiman D; Li F; Wu X; Guo L; Li W; Gao S; He J
Cancer Cell Int; 2022 Jan; 22(1):49. PubMed ID: 35093072
[TBL] [Abstract][Full Text] [Related]
5. Spindle apparatus coiled-coil protein 1 (SPDL1) serves as a novel prognostic biomarker in triple-negative breast cancer.
Yang XY; Zheng XX; Zhai XJ; Tang T; Yu SC
Proteomics Clin Appl; 2024 Feb; ():e2300002. PubMed ID: 38316615
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma.
Klimaszewska-Wiśniewska A; Neska-Długosz I; Buchholz K; Durślewicz J; Grzanka D; Kasperska A; Antosik P; Zabrzyński J; Grzanka A; Gagat M
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208606
[TBL] [Abstract][Full Text] [Related]
7. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
8. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
[TBL] [Abstract][Full Text] [Related]
9. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.
Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y
Front Immunol; 2022; 13():970588. PubMed ID: 36148233
[TBL] [Abstract][Full Text] [Related]
10. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle.
Albahde MAH; Zhang P; Zhang Q; Li G; Wang W
Front Oncol; 2020; 10():49. PubMed ID: 32117719
[No Abstract] [Full Text] [Related]
11. Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma.
Xie H; Lin J; Thomas DG; Jiang W; Liu X
Int J Clin Exp Pathol; 2012; 5(4):347-55. PubMed ID: 22670179
[TBL] [Abstract][Full Text] [Related]
12. Independent prognostic implications of
Ma C; Luo H; Cao J; Gao C; Fa X; Wang G
J Cancer; 2020; 11(23):7009-7022. PubMed ID: 33123291
[No Abstract] [Full Text] [Related]
13. SPDL1 Overexpression Is Associated With the 18F-FDG PET/CT Metabolic Parameters, Prognosis, and Progression of Esophageal Cancer.
Liu HS; Guo Q; Yang H; Zeng M; Xu LQ; Zhang QX; Liu H; Guo JL; Zhang J
Front Genet; 2022; 13():798020. PubMed ID: 35664322
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology.
Ha H; Bang JH; Nam AR; Park JE; Jin MH; Bang YJ; Oh DY
Cancer Res Treat; 2019 Apr; 51(2):832-840. PubMed ID: 30309223
[TBL] [Abstract][Full Text] [Related]
16. Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
Gagat M; Krajewski A; Grzanka D; Grzanka A
Oncol Rep; 2018 Jul; 40(1):123-144. PubMed ID: 29767233
[TBL] [Abstract][Full Text] [Related]
17. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
[TBL] [Abstract][Full Text] [Related]
18. Identification of significant prognostic risk markers for pancreatic ductal adenocarcinoma: a bioinformatic analysis.
Zhang Z; Sun W; Zeng Z; Lu Y
Acta Biochim Pol; 2022 Jun; 69(2):327-333. PubMed ID: 35675627
[TBL] [Abstract][Full Text] [Related]
19. MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM.
Kodama T; Marian TA; Lee H; Kodama M; Li J; Parmacek MS; Jenkins NA; Copeland NG; Wei Z
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23625-23635. PubMed ID: 31690663
[TBL] [Abstract][Full Text] [Related]
20. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation.
Xu Y; Wang Y; Chen Q; Yao T; Qiu J; Ni L; Chen H; Liang T
Pancreatology; 2023 Dec; 23(8):1003-1013. PubMed ID: 37923686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
